JMP Securities Boosts Pharvaris (NASDAQ:PHVS) Price Target to $49.00

Pharvaris (NASDAQ:PHVS – Free Report) had its price target hoisted by JMP Securities from $40.00 to $49.00 in a research report released on Tuesday, Benzinga reports. JMP Securities currently has a market outperform rating on the stock. Other analysts also recently issued research reports about the stock. Wedbush decreased their price target on shares of […]

Related Keywords

United States ,America , ,Qube Research Technologies Ltd ,Tower Research Capital ,Morgan Stanley ,America Corp ,Schonfeld Strategic Advisors ,Free Report ,Moderate Buy ,Get Free Report ,Technologies Ltd ,Research Capital ,Pharvaris Daily ,Pharvaris ,Nasdaq Phvs ,Phvs ,Medical ,Boost Price Target ,Jmp Securities ,